Determinants of Breast Cancer Screening Practice among Women in Indonesia: A Nationwide Study.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 May 2021
Historique:
received: 23 12 2020
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 26 11 2021
Statut: epublish

Résumé

Breast cancer remains the leading cause of death for women globally, including in Indonesia. Breast cancer screening plays a vital role in reducing deaths caused by breast cancer. However, breast cancer screening rate is still low and studies on determinants for breast cancer screening is limited in Indonesia. This study aimed to identify the determinants of breast cancer screening among women in Indonesia. This population-based study was conducted among 827 women who lived in either rural and urban areas, using a stratified sampling design where were based on province and locality combinations. Data were analysed using a binary logistic regression model to assess the associations between independent and dependent variables. As many as 827 women with an average age of 29.91 (± 11.14) years old participated in this study. The overall breast cancer screening among women was 18.74%. Knowledge of breast cancer risk factors, signs, and symptoms (adj.OR = 1.75, 95%CI: 1.20 - 2.56), age of 35 to 39 years old (adj.OR. = 1.52, 95% CI: 1.02 - 2.26), and household income of ≥6,000,000 IDR (≥457 USD) (adj.OR. = 5.19, 95%CI: 1.43-18.84) were associated with breast cancer screening attendance. In contrast, Christian women had a significantly lower breast cancer screening rate that women from other religions (adj. OR. = 0.45, 95%CI: 0.24 - 0.85). The overall breast cancer screening attendance was poor among Indonesian women population. Age, household income, religion, and knowledge of breast cancer risk factors were identified as the determinant factors for breast cancer screening.

Sections du résumé

BACKGROUND BACKGROUND
Breast cancer remains the leading cause of death for women globally, including in Indonesia. Breast cancer screening plays a vital role in reducing deaths caused by breast cancer. However, breast cancer screening rate is still low and studies on determinants for breast cancer screening is limited in Indonesia. This study aimed to identify the determinants of breast cancer screening among women in Indonesia.
METHODS METHODS
This population-based study was conducted among 827 women who lived in either rural and urban areas, using a stratified sampling design where were based on province and locality combinations. Data were analysed using a binary logistic regression model to assess the associations between independent and dependent variables.
RESULTS RESULTS
As many as 827 women with an average age of 29.91 (± 11.14) years old participated in this study. The overall breast cancer screening among women was 18.74%. Knowledge of breast cancer risk factors, signs, and symptoms (adj.OR = 1.75, 95%CI: 1.20 - 2.56), age of 35 to 39 years old (adj.OR. = 1.52, 95% CI: 1.02 - 2.26), and household income of ≥6,000,000 IDR (≥457 USD) (adj.OR. = 5.19, 95%CI: 1.43-18.84) were associated with breast cancer screening attendance. In contrast, Christian women had a significantly lower breast cancer screening rate that women from other religions (adj. OR. = 0.45, 95%CI: 0.24 - 0.85).
CONCLUSION CONCLUSIONS
The overall breast cancer screening attendance was poor among Indonesian women population. Age, household income, religion, and knowledge of breast cancer risk factors were identified as the determinant factors for breast cancer screening.

Identifiants

pubmed: 34048171
doi: 10.31557/APJCP.2021.22.5.1435
pmc: PMC8408399
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1435-1441

Références

Ethn Health. 2019 Jul;24(5):544-559
pubmed: 28678532
Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):146-152
pubmed: 28900322
Lancet Glob Health. 2016 Dec;4(12):e923-e935
pubmed: 27855871
Oncologist. 2018 Apr;23(4):440-453
pubmed: 29284758
Yonsei Med J. 2018 Nov;59(9):1026-1033
pubmed: 30328316
PLoS One. 2018 Mar 26;13(3):e0194996
pubmed: 29579131
Asian Pac J Cancer Prev. ;18(9):2409-2417
pubmed: 28950697
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Int J Cancer. 2019 Aug 15;145(4):994-1006
pubmed: 30762235
JAMA. 2015 Oct 20;314(15):1599-614
pubmed: 26501536
BMC Womens Health. 2020 Jun 3;20(1):116
pubmed: 32493375
J Immigr Minor Health. 2021 Feb;23(1):95-102
pubmed: 32451692
BMC Public Health. 2015 Nov 23;15:1163
pubmed: 26596507
Int J Cancer. 2015 Oct 15;137(8):1990-9
pubmed: 25895135
Asian Pac J Cancer Prev. 2015;16(8):3463-71
pubmed: 25921163
Am J Nurs. 2018 Jul;118(7):34-41
pubmed: 29905576
Asian Pac J Cancer Prev. 2016;17(8):3887-95
pubmed: 27644635
Health Soc Care Community. 2020 Sep;28(5):1772-1779
pubmed: 32304270
BMC Public Health. 2017 Mar 20;17(1):270
pubmed: 28320350
J Pediatr Nurs. 2019 Sep - Oct;48:e27-e34
pubmed: 31253520
Int J Equity Health. 2018 Apr 3;17(1):41
pubmed: 29615036
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Eur J Cancer. 2020 Mar;127:191-206
pubmed: 31932175
Health Educ Behav. 2015 Oct;42(5):633-41
pubmed: 25869406
AJR Am J Roentgenol. 2018 Feb;210(2):264-270
pubmed: 29064760
Climacteric. 2018 Jun;21(3):209-213
pubmed: 29419315
Int J Cancer. 2017 Oct 1;141(7):1295-1306
pubmed: 28542784
Breast Cancer (Auckl). 2018 Jan 08;12:1178223417752677
pubmed: 29434475
BMJ Open. 2019 Aug 26;9(8):e028705
pubmed: 31455705
BMC Cancer. 2017 Apr 20;17(1):284
pubmed: 28427373
BMC Cancer. 2018 Mar 6;18(1):208
pubmed: 29506486
J Res Health Sci. 2020 Feb 16;20(1):e00467
pubmed: 32814688
Pan Afr Med J. 2019 Jun 26;33:144
pubmed: 31565116
J Natl Med Assoc. 2020 Dec;112(6):578-592
pubmed: 32641257
Heliyon. 2020 Apr 27;6(4):e03838
pubmed: 32373741
Asian Pac J Cancer Prev. 2018 Apr 25;19(4):997-1003
pubmed: 29693968

Auteurs

Solikhah Solikhah (S)

Faculty of Public Health, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.

Lianawati Lianawati (L)

Faculty of Public Health, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.

Ratu Matahari (R)

Faculty of Public Health, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.

Dwi Sarwani Sri Rejeki (DSS)

Department of Public Health, Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto, Indonesia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH